A
AEON Biopharma, Inc. (AEON)
ASE – Real vaqt narxi. Valyuta: USD
0.27
-0.00 (-0.40%)
Bozor ochiq: Aug 12, 2026, 3:21 PM EDT
0.28
+0.01 (2.23%)
Oldingi bozordan keyin: Aug 11, 2026, 7:38 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.27
-0.00 (-0.40%)
Bozor ochiq: Aug 12, 2026, 3:21 PM EDT
0.28
+0.01 (2.23%)
Oldingi bozordan keyin: Aug 11, 2026, 7:38 PM EDT
AEON Biopharma, Inc., klinik tadqiqot bosqichidagi biofarmatsevtika kompaniyasi, botulinum toksinlarini ishlab chiqishga qaratilgan. U og'ir tibbiy sharoitlar uchun ABP-450 (prabotulinumtoxinA) in'ektsiyasini ishlab chiqadi, bu servikal distoniya davolash uchun 2-bosqich tadqiqotini yakunlagan va surunkali va epizodik migrenni davolash uchun 2-bosqich tadqiqotini olib bormoqda. Kompaniya, shuningdek, ABP-450ni gastroparez va post-travmatik stress buzilishini davolash uchun ishlab chiqadi. Kompaniya Daewoong Pharmaceutical Co., LTD. va Viatris Inc. bilan litsenzion shartnomalarga ega. Kompaniya Kaliforniyaning Irvayn shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Chad K. Oh M.D. | Chief Medical Officer |
| Mr. Alex Wilson | Chief Legal & Strategy Officer and Corporate Secretary |
| Mr. John A. Bencich M.B.A. | Chief Financial Officer |
| Mr. Robert Bancroft | President, CEO & Director |
| Ms. Jennifer Sy | Chief Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-03 | 8-K | aeon-20260803x8k.htm |
| 2026-07-23 | 8-K | aeon-20260723x8k.htm |
| 2026-07-15 | 8-K | aeon-20260713x8k.htm |
| 2026-07-13 | S-1MEF | tm2615250d9_s1mef.htm |
| 2026-07-09 | S-1/A | tm2615250-6_s1a.htm |
| 2026-07-08 | S-1 | tm2615250-3_s1.htm |
| 2026-06-17 | 8-K | aeon-20260617x8k.htm |
| 2026-05-29 | DRS | filename1.htm |
| 2026-05-14 | 8-K | aeon-20260514x8k.htm |
| 2026-04-29 | DEFA14A | aeon-20231109xdefa14a.htm |